No Data
No Data
Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
ROCHESTER, N.Y., March 27, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (NASDAQ:VCNX) ("Vaccinex" or the "Company"), a clinical-stage biotechnology company pioneering a differentiated approach to treating Alzheimer's
Vaccinex CFO Scott Royer to Retire, Jill Sanchez Steps in
Sector Update: Health Care Stocks Slipping Wednesday Afternoon
Health care stocks were easing Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both down about 0.4%. The iShares Biotechnology ETF (IBB) fell 0.3
Vaccinex Shares Rise as Company Announces Eight New Deals for Antibody Discovery Platform
Vaccinex (VCNX) shares rose 9.3% in recent trading Wednesday after the biotech company announced eight new agreements allowing the use of its proprietary ActivMAb platform in discovering antibodies ag
Teladoc Health, Avinger Among Healthcare Movers
Vaccinex Announces Multiple New Agreements for Access to ActivMAb Antigen Virus Technology
Eight new antibody discovery agreements incorporate Vaccinex's powerful ActivMAb Drug Discovery Platform ActivMab platform enables the discovery and development of high value antibodies against challe
No Data